Product Recalls in Vermont

Product recalls affecting Vermont — including food, drugs, consumer products, medical devices, and vehicles distributed to Vermont. RecallDetector monitors distribution data from the FDA, USDA, CPSC, and NHTSA to show you which recalls are relevant to your area. 2,541 recalls have been distributed to Vermont in the last 12 months.

47,027 total recalls
2,541 in last 12 months

Showing 29012920 of 13,356 recalls

DrugMay 6, 2022· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: medroxyPROGESTERone Acetate Injectable Suspension Recalled by SUN...

The Issue: Lack of assurance of sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 6, 2022· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: medroxyPROGESTERone Acetate Injectable Suspension Recalled by SUN...

The Issue: Lack of assurance of sterility

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 5, 2022· Vi-Jon, LLC

Recalled Item: Equate Tartar Control Plus (Eucalyptol 0.092% Recalled by Vi-Jon, LLC Due to...

The Issue: Superpotent Drug: product complaint for milky blue appearance and...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugMay 3, 2022· American Health Packaging

Recalled Item: Nitrofurantoin Capsules Recalled by American Health Packaging Due to Failed...

The Issue: Failed Dissolution Specifications: Nitrofurantoin Capsules recalled due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 3, 2022· Apotex Corp.

Recalled Item: Sirolimus Oral Solution Recalled by Apotex Corp. Due to Failed Dissolution...

The Issue: Failed Dissolution Specifications: Sirolimus Oral Solution recalled due to...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugMay 2, 2022· Amgen, Inc.

Recalled Item: MVASI (bevacizumab-awwb) Recalled by Amgen, Inc. Due to Defective container:...

The Issue: Defective container: loose crimp defect, potential loss of container integrity.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 29, 2022· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: buPROPion Hydrochloride Extended-Release Tablet Recalled by SUN...

The Issue: Presence Of Foreign Substance: Customer complaint for the presence of dark,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 29, 2022· SUN PHARMACEUTICAL INDUSTRIES INC

Recalled Item: buPROPion Hydrochloride Extended-Release Tablet Recalled by SUN...

The Issue: Presence Of Foreign Substance: Customer complaint for the presence of dark,...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class III — Low RiskOngoing
Refund
DrugApril 28, 2022· Viatris Inc

Recalled Item: alprazolam XR extended-release tablets Recalled by Viatris Inc Due to Failed...

The Issue: Failed Dissolution Specifications: low out-of-specification dissolution test...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 28, 2022· Viatris Inc

Recalled Item: Xanax XR (alprazolam) extended-release tablets Recalled by Viatris Inc Due...

The Issue: Failed Dissolution Specifications: low out of specification results for...

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 27, 2022· Lupin Pharmaceuticals Inc.

Recalled Item: GaviLyte -C (Polyethylene Glycol 3350 Recalled by Lupin Pharmaceuticals Inc....

The Issue: Failed Stability Specification

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· SCA Pharmaceuticals

Recalled Item: Vancomycin HCl 1.5 g in 0.9% Sodium Chloride Recalled by SCA Pharmaceuticals...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· SCA Pharmaceuticals

Recalled Item: Norepinephrine 8mg in 0.9% Sodium Chloride 250 mL bag Recalled by SCA...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· SCA Pharmaceuticals

Recalled Item: Fentanyl 2mcg/ml and Bupivacaine 0.125% in 0.9% Sodium Chloride 100 mL bags...

The Issue: CGMP Deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules USP Recalled by Glenmark Pharmaceuticals Inc., USA Due...

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 25, 2022· Glenmark Pharmaceuticals Inc., USA

Recalled Item: Zonisamide Capsules Recalled by Glenmark Pharmaceuticals Inc., USA Due to...

The Issue: cGMP deviations

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 20 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 10 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund
DrugApril 22, 2022· Pfizer Inc.

Recalled Item: Accupril (Quinapril HCl Tablets) 40 mg Recalled by Pfizer Inc. Due to CGMP...

The Issue: CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.

Recommended Action: Stop taking this medication. Contact your pharmacy or healthcare provider.

Class II — Potential Health HazardOngoing
Refund